Cannabis Hyperemesis Gets Worse Each Time: A New Sensitization Theory
A verified CHS case showed progressive worsening with each episode — even after prolonged abstinence and relapse — inspiring a new 'hypersensitization hypothesis' for how CHS develops and persists.
Quick Facts
What This Study Found
Diagnostically verified CHS case (confirmed by 12+ months abstinence) showed each vomiting episode was more severe than the previous, even during cannabis relapse after prolonged abstinence, suggesting ongoing sensitization of the emetic pathway.
Key Numbers
Elevated blood THC and THC-COOH levels 3 weeks after abstinence; each CHS episode stronger than the previous; 12-month abstinence period diagnostically reliable for confirming CHS vs. CVS.
How They Did This
Case report of an adult cannabis user with verified CHS (prolonged abstinence confirmation), with blood cannabinoid levels showing persistent elevation 3 weeks after cessation, and a novel hypersensitization hypothesis proposed.
Why This Research Matters
Most CHS cases in literature lack proper verification — this diagnostically sound case reveals that CHS may involve permanent sensitization, not just temporary irritation, changing how we understand the condition.
The Bigger Picture
The hypersensitization hypothesis explains why CHS patients often have escalating severity — and why haloperidol and topical capsaicin provide relief: they may counteract the sensitized emetic pathways.
What This Study Doesn't Tell Us
Single case report; hypersensitization hypothesis is speculative and requires experimental validation; persistent blood cannabinoid levels may confound abstinence-based diagnosis.
Questions This Raises
- ?Is CHS sensitization reversible with sufficient abstinence duration?
- ?Could early intervention prevent the sensitization cascade?
Trust & Context
- Key Stat:
- Evidence Grade:
- Single case report but diagnostically rigorous with 12-month abstinence verification, contributing a novel pathophysiological hypothesis.
- Study Age:
- Published in 2026, advancing understanding of CHS pathophysiology with a novel sensitization framework.
- Original Title:
- Cannabis hyperemesis syndrome: the rare case of a valid diagnosis plus hypersensitization hypothesis for development and chronification of this severe somatic cannabis use disorder.
- Published In:
- Fortschritte der Neurologie-Psychiatrie (2026)
- Authors:
- Bonnet, Udo(8)
- Database ID:
- RTHC-08131
Evidence Hierarchy
Frequently Asked Questions
Does cannabis hyperemesis syndrome get worse over time?
This case report found each episode was more severe than the last, even after periods of abstinence — suggesting the body becomes progressively sensitized to cannabis's emetic effects.
How is CHS properly diagnosed?
True CHS requires symptoms to completely and persistently resolve during cannabis abstinence. This paper notes that 12 months of observation is diagnostically reliable, making most published cases merely 'suspected' CHS.
Read More on RethinkTHC
Cite This Study
https://rethinkthc.com/research/RTHC-08131APA
Bonnet, Udo. (2026). Cannabis hyperemesis syndrome: the rare case of a valid diagnosis plus hypersensitization hypothesis for development and chronification of this severe somatic cannabis use disorder.. Fortschritte der Neurologie-Psychiatrie. https://doi.org/10.1055/a-2731-3369
MLA
Bonnet, Udo. "Cannabis hyperemesis syndrome: the rare case of a valid diagnosis plus hypersensitization hypothesis for development and chronification of this severe somatic cannabis use disorder.." Fortschritte der Neurologie-Psychiatrie, 2026. https://doi.org/10.1055/a-2731-3369
RethinkTHC
RethinkTHC Research Database. "Cannabis hyperemesis syndrome: the rare case of a valid diag..." RTHC-08131. Retrieved from https://rethinkthc.com/research/bonnet-2026-cannabis-hyperemesis-syndrome-the
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.